
NRx Pharmaceuticals Files Breakthrough Therapy Designation Request for ZYESAMI
RADNOR, PA — NRx Pharmaceuticals (Nasdaq: NRXP) announced that it recently filed a new Breakthrough Therapy Designation (BTD) request with the US Food and Drug Administration (FDA) focused on patients …
NRx Pharmaceuticals Files Breakthrough Therapy Designation Request for ZYESAMI Read More